Pharma and Cetirizine OTC Market

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

Pharma and Cetirizine OTC Market contains market size and forecasts of Pharma and Cetirizine OTC in global, including the following market information:

• Global Pharma and Cetirizine OTC Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Pharma and Cetirizine OTC Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Pharma and Cetirizine OTC companies in 2021 (%)

The global Pharma and Cetirizine OTC market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharma and Cetirizine OTC include J & J, SANOFI-AVENTIS US LLC, PL DEVELOPMENTS INC, APOTEX, Teva, MCKESSON CORP, Perrigo, Taro Pharmaceutical and CVS Pharmacy, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma and Cetirizine OTC manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharma and Cetirizine OTC Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pharma and Cetirizine OTC Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Capsule

Global Pharma and Cetirizine OTC Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pharma and Cetirizine OTC Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Drug Store
• Other

Global Pharma and Cetirizine OTC Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pharma and Cetirizine OTC Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Pharma and Cetirizine OTC revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Pharma and Cetirizine OTC revenues share in global market, 2021 (%)
• Key companies Pharma and Cetirizine OTC sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Pharma and Cetirizine OTC sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• J & J
• SANOFI-AVENTIS US LLC
• PL DEVELOPMENTS INC
• APOTEX
• Teva
• MCKESSON CORP
• Perrigo
• Taro Pharmaceutical
• CVS Pharmacy
• Major? Pharmaceuticals
• Mylan
• Amneal
• NOVARTIS
• Cardinal
• Jubilant Life Sciences
• Novel Laboratories
• Medline
• Macleods
• Torrent Pharmaceuticals
• Micro Labs Limited
• Dr. Reddy's Laboratories
• Cipla
• Aurobindo Pharma
• Glenmark
• Synthon
• Magno-Humphries
• Unique Pharmaceutical
• ALLEGIANT HEALTH
• Silarx Pharmaceuticals
• Sun Pharma
• UNICHEM LABORATORIES LTD
• Pro Doc Limitee
• NorthStar Rx LLC
• ACETO
• Strides Shasun